BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bech P, Martin N, Ramachandran R, Bloom S. The biochemical utility of chromogranin A, chromogranin B and cocaine- and amphetamine-regulated transcript for neuroendocrine neoplasia. Ann Clin Biochem 2014;51:8-21. [DOI: 10.1177/0004563213489670] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Jun E, Kim SC, Song KB, Hwang DW, Lee JH, Shin SH, Hong SM, Park K, Lee Y. Diagnostic value of chromogranin A in pancreatic neuroendocrine tumors depends on tumor size: A prospective observational study from a single institute. Surgery 2017;162:120-30. [DOI: 10.1016/j.surg.2017.01.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
2 Szarvas T, Csizmarik A, Fazekas T, Hüttl A, Nyirády P, Hadaschik B, Grünwald V, Püllen L, Jurányi Z, Kocsis Z, Shariat SF, Sevcenco S, Maj-Hes A, Kramer G. Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer. BJU Int 2021;127:44-55. [PMID: 32314509 DOI: 10.1111/bju.15086] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Chu S, Chen P, Chen J, Yu C, Hsieh Y, Kuo D. Role of hypothalamic leptin-LepRb signaling in NPY-CART-mediated appetite suppression in amphetamine-treated rats. Hormones and Behavior 2018;98:173-82. [DOI: 10.1016/j.yhbeh.2017.12.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Monaghan P, Lamarca A, Valle J, Hubner R, Mansoor W, Trainer P, Darby D. Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours. Clin Endocrinol 2016;84:348-52. [DOI: 10.1111/cen.12985] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
5 Halfdanarson TR, Howe JR, Haraldsdottir S, O'dorisio TM. Circulating tumor markers in patients with neuroendocrine tumors – a clinical perspective. International Journal of Endocrine Oncology 2015;2:89-99. [DOI: 10.2217/ije.14.38] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Pavel ME, Phan AT, Wolin EM, Mirakhur B, Liyanage N, Pitman Lowenthal S, Fisher GA Jr, Vinik AI; CLARINET Study Investigators. Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors. Oncologist 2019;24:463-74. [PMID: 30355775 DOI: 10.1634/theoncologist.2018-0217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
7 Hontani K, Tsuchikawa T, Hiwasa T, Nakamura T, Ueno T, Kushibiki T, Takahashi M, Inoko K, Takano H, Takeuchi S, Dosaka-Akita H, Kuwatani M, Sakamoto N, Hatanaka Y, Mitsuhashi T, Shimada H, Shichinohe T, Hirano S. Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors. Oncotarget 2017;8:106206-21. [PMID: 29290942 DOI: 10.18632/oncotarget.22175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
8 Hackenmueller SA. Challenges with Validating Nonharmonized Assays. J Appl Lab Med 2019;4:1-3. [PMID: 31639700 DOI: 10.1373/jalm.2019.029272] [Reference Citation Analysis]
9 Rehfeld JF. Chromogranin A in gastrinomas: Promises and pitfalls. Clin Chim Acta 2015;446:15-20. [PMID: 25861845 DOI: 10.1016/j.cca.2015.03.039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Modlin IM, Bodei L, Kidd M. Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms. Best Pract Res Clin Endocrinol Metab. 2016;30:59-77. [PMID: 26971844 DOI: 10.1016/j.beem.2016.01.002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 7.7] [Reference Citation Analysis]
11 Rehfeld JF, Broedbaek K, Goetze JP, Knigge U, Hilsted LM. True Chromogranin A concentrations in plasma from patients with small intestinal neuroendocrine tumours. Scandinavian Journal of Gastroenterology 2020;55:565-73. [DOI: 10.1080/00365521.2020.1759141] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]